Atlas Trials

Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

Clinical trial NCT01085617 · COMPLETED

Trial details

NCT number
NCT01085617
Sponsor
University College, London
Status
COMPLETED
Study type
INTERVENTIONAL
LeukemiaMucositisOral Complications
Start date
2010-12-01
Primary completion
2025-02-24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.